ATE130603T1 - Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate. - Google Patents
Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate.Info
- Publication number
- ATE130603T1 ATE130603T1 AT92913037T AT92913037T ATE130603T1 AT E130603 T1 ATE130603 T1 AT E130603T1 AT 92913037 T AT92913037 T AT 92913037T AT 92913037 T AT92913037 T AT 92913037T AT E130603 T1 ATE130603 T1 AT E130603T1
- Authority
- AT
- Austria
- Prior art keywords
- decarboxyl
- azylthioalkyl
- oxalone
- prostagladin
- hypotensive
- Prior art date
Links
- 208000001953 Hypotension Diseases 0.000 title 1
- 208000021822 hypotensive Diseases 0.000 title 1
- 230000001077 hypotensive effect Effects 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/702,220 US5312832A (en) | 1991-05-17 | 1991-05-17 | Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE130603T1 true ATE130603T1 (de) | 1995-12-15 |
Family
ID=24820309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92913037T ATE130603T1 (de) | 1991-05-17 | 1992-05-13 | Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5312832A (de) |
| EP (1) | EP0585380B1 (de) |
| JP (1) | JPH06507897A (de) |
| AT (1) | ATE130603T1 (de) |
| AU (1) | AU653240B2 (de) |
| CA (1) | CA2102295A1 (de) |
| DE (1) | DE69206262T2 (de) |
| ES (1) | ES2079872T3 (de) |
| HU (1) | HUT65913A (de) |
| WO (1) | WO1992020648A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312842A (en) * | 1992-10-30 | 1994-05-17 | Allergan, Inc. | Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives |
| US5516796A (en) * | 1994-03-24 | 1996-05-14 | Kabi Pharmacia Ab | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof |
| WO2000051980A1 (en) | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | C16 unsaturated fp-selective prostaglandins analogs |
| EP1202999B1 (de) | 1999-08-04 | 2003-06-18 | The Procter & Gamble Company | Neue 2-decarboxy-2-phosphinico prostaglandin f analoge |
| US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| EP1984387B1 (de) * | 2006-02-16 | 2017-05-31 | Sederma | Kxk-polypeptide und deren verwendung |
| US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) * | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7605381A (nl) * | 1975-05-26 | 1976-11-30 | Schering Ag | Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking. |
| JPS5334747A (en) * | 1976-09-14 | 1978-03-31 | Ono Pharmaceut Co Ltd | Prostaglandin-like compounds and their preparation |
| DE3168199D1 (en) * | 1980-10-31 | 1985-02-21 | Teijin Ltd | Novel thiaprostaglandin e1 derivatives, process for production thereof, and pharmaceuticals containing these compounds |
| US5238961A (en) * | 1990-06-14 | 1993-08-24 | Allergan, Inc. | Pgf 1-alcohols and their use as ocular hypotensives |
-
1991
- 1991-05-17 US US07/702,220 patent/US5312832A/en not_active Expired - Fee Related
-
1992
- 1992-05-13 JP JP5500151A patent/JPH06507897A/ja active Pending
- 1992-05-13 EP EP92913037A patent/EP0585380B1/de not_active Expired - Lifetime
- 1992-05-13 CA CA002102295A patent/CA2102295A1/en not_active Abandoned
- 1992-05-13 WO PCT/US1992/003969 patent/WO1992020648A1/en not_active Ceased
- 1992-05-13 HU HU9303242A patent/HUT65913A/hu unknown
- 1992-05-13 AU AU20066/92A patent/AU653240B2/en not_active Ceased
- 1992-05-13 AT AT92913037T patent/ATE130603T1/de not_active IP Right Cessation
- 1992-05-13 DE DE69206262T patent/DE69206262T2/de not_active Expired - Fee Related
- 1992-05-13 ES ES92913037T patent/ES2079872T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU653240B2 (en) | 1994-09-22 |
| HUT65913A (en) | 1994-07-28 |
| US5312832A (en) | 1994-05-17 |
| DE69206262D1 (de) | 1996-01-04 |
| CA2102295A1 (en) | 1992-11-18 |
| ES2079872T3 (es) | 1996-01-16 |
| JPH06507897A (ja) | 1994-09-08 |
| WO1992020648A1 (en) | 1992-11-26 |
| EP0585380B1 (de) | 1995-11-22 |
| EP0585380A1 (de) | 1994-03-09 |
| AU2006692A (en) | 1992-12-30 |
| DE69206262T2 (de) | 1996-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE269290T1 (de) | Benzoylderivate | |
| ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
| ES533338A0 (es) | Derivados de la 2-pirimidinil-1-piperazina | |
| GR1001619B (el) | Παράγωγα ινδόλης. | |
| ATE158506T1 (de) | Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine | |
| ATE130603T1 (de) | Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate. | |
| SE8703854D0 (sv) | Prostaglandinderivat for behandling av glaukom eller okuler hypertension | |
| CO4230097A1 (es) | Piridopirimidinas sustituidas como antihipertensivos | |
| NO871861D0 (no) | Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer. | |
| ES2096941T3 (es) | 27-hidroxirrapamicina y derivados de la misma. | |
| FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
| FR2367742A1 (fr) | Derives d'a-thio-alcanoiques, leur preparation et leur utilisation | |
| ATE73768T1 (de) | 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8inter-m-phenylene-pgi2-derivate. | |
| ATE98239T1 (de) | 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2derivate. | |
| ES2059396T3 (es) | Derivados de indeno y metodos. | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| WO1992010473A3 (en) | 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives | |
| ES2139934T3 (es) | Procedimiento mejorado para preparar derivados de cadena lateral de ciclohexapeptidil lipopeptidos. | |
| FR2378518A1 (fr) | Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne | |
| ATE164763T1 (de) | Okulare hypotensive homo-prostaglandinderivate | |
| NO921317L (no) | Antimetastatisk virkende midler | |
| DE69601451D1 (de) | UCK14-Verbindungen | |
| FR2361871A1 (fr) | 11-desoxy-16-arylprostaglandines 13-acetyleniques | |
| FR2401136A1 (fr) | Derives de type isothio-uree | |
| BG45852A3 (en) | Method for preparing of n- acyl- l- propyline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |